DJIA 17,804.80 26.65 0.15%
NASDAQ 4,765.38 16.98 0.36%
S&P 500 2,070.65 9.42 0.46%
market minute promo

Geron Corp (NASDAQ: GERN)

company name or ticker

Geron (GERN) Stock Surges After FDA Removes Full Clinical Hold on Imetelstat Application

Sapient surges on Publicis buyout: Big U.S. stock movers

Betting On Big Data To Beat Aging

Is Sarepta Therapeutics Inc. Stock a Short Sell?

Clinical stage biopharma Sarepta Therapeutics has attracted a large and growing short interest. Is the stock now a good short sell?

At Current Levels, Geron Has A Very Favorable Risk/Reward Profile

The Next Industry Google Plans to Transform

Google is leveraging its vast resources to create high-impact technologies that could transform modern medicine. Here is what you need to know.

Geron (GERN) Strong On High Relative Volume Today

Geron's Imetelstat: No Threat Now Or Possibly Ever To Incyte's Jakafi Franchise

Why Geron Corporation Stock Is Down a Shocking 52% in 2014

The FDA's clinical hold on imetelstat has rocked Geron's shares this year.

Living Longer And Making Money: Life Extending Businesses

See More Articles...